Class of Stock [Axis]
Series Aand B Preferred Stock [Member]
Equity Components [Axis]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Geographical [Axis]
NEW JERSEY
Income Tax Authority, Name [Axis]
New Jersey Division of Taxation [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Financial Instrument [Axis]
US Treasury Securities [Member]
Corporate Debt Securities [Member]
Credit Facility [Axis]
Silicon Valley Bank [Member]
Measurement Frequency [Axis]
Fair Value, Recurring [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Fair Value, Nonrecurring [Member]
Inprocess R&D [Member]
Business Acquisition [Axis]
EGEN Inc [Member]
Legal Entity [Axis]
IPR&D Drug Technology Platforms [Member]
Finite-Lived Intangible Assets by Major Class [Axis]
In Process Research and Development [Member]
Asset Class [Axis]
IPR And D [Member]
Long-Lived Tangible Asset [Axis]
Machinery and Equipment [Member]
Furniture and Fixtures [Member]
Leasehold Improvements [Member]
Lender Name [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Horizon Technology Finance Corporation [Member]
New Jersey [Member]
Income Tax Authority [Axis]
Domestic Tax Authority [Member]
Federal Income Tax [Member]
Scenario [Axis]
No Expiration [Member]
State and Local Jurisdiction [Member]
Award Type [Axis]
2021 Registration Statement [Member]
Baby Shelf Limitation [Member]
Market Offering Agreement [Member]
Series A Convertible Redeemable Preferred Stock [Member]
Series B Convertible Redeemable Preferred Stock [Member]
Securities Purchase Agreement [Member]
Sale of Stock [Axis]
April 2022 Registered Direct Offering [Member]
Plan Name [Axis]
2018 Stock Incentive Plan [Member]
Inducement Option Grants [Member]
Title of Individual [Axis]
Five New Employees [Member]
Restricted Stock [Member]
Equity Stock Awards [Member]
Granted Under 2018 Plan and 2007 Plan [Member]
Inducement Awards [Member]
Stock Options and Restricted Stock Awards [Member]
Income Statement Location [Axis]
Research and Development Expense [Member]
General and Administrative Expense [Member]
Share-Based Payment Arrangement, Option [Member]
Exercise Price Range [Axis]
Exercise Price One [Member]
Exercise Price Two [Member]
Exercise Price Three [Member]
Amended Asset Purchase Agreement [Member]
Related Party Transaction [Axis]
Within One Year of Achieving Milestone [Member]
EGWC, Inc [Member]
10 Business Days of Achieving Milestone [Member]
Lease Agreement [Member]
Legal Entity of Counterparty, Type [Axis]
Hisun [Member]
Convertible Note Purchase Agreement [Member]
Transomic Technologies, Inc. [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Auditor Name
Auditor Location
Auditor Firm ID
Statement of Financial Position [Abstract]
ASSETS
Current assets:
Cash and cash equivalents
Investment in debt securities - available for sale, at fair value
Accrued interest receivable on investment securities
Money market investments, restricted cash
Advances and deposits on clinical programs and other current assets
Total current assets
Property and equipment (at cost, less accumulated depreciation and amortization)
Other assets:
Money market investments, restricted cash
Deferred income tax asset
Operating lease right-of-use assets, net
Deposits and other assets
Total other assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable – trade
Other accrued liabilities
Notes payable – current portion, net of deferred financing costs
Operating lease liabilities - current portion
Total current liabilities
Notes payable – non-current portion, net of deferred financing costs
Operating lease liabilities - non-current portion
Total liabilities
Commitments and contingencies
Stockholders’ equity:
Preferred Stock - $0.01 par value (100,000 shares authorized, and no shares issued or outstanding at December 31, 2023 and 2022)
Common stock - $0.01 par value (112,500,000 shares authorized; 9,399,811 and 7,436,219 shares issued at December 31, 2023 and 2022, respectively, and 9,399,789 and 7,436,197 shares outstanding at December 31, 2023 and 2022, respectively)
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total stockholders’ equity before treasury stock
Treasury stock, at cost (22 shares at December 31, 2023 and 2022)
Total stockholders’ equity
Total liabilities and stockholders’ equity
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Treasury stock, shares
Income Statement [Abstract]
Licensing revenue
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense):
Gain from change in earn-out milestone liability
Impairment of in-process research and development
Loss on debt extinguishment
Investment income, net
Interest expense
Other (loss) income
Total other income (expense), net
Loss before income tax benefit
Income tax benefit
Net loss
Net loss per common share - Basic
Net loss per common share - Diluted
Weighted average common shares outstanding - Basic
Weighted average common shares outstanding - Diluted
Statement of Comprehensive Income [Abstract]
Other comprehensive loss
Changes in:
Realized gains on investment securities recognized in investment income, net
Unrealized losses on investment securities, net
Change in realized and unrealized gains on available for sale securities, net
Net loss
Total comprehensive loss
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Amortization of right-of-use assets
Recognition of deferred revenue
Realized and unrealized losses, net, on investment securities
Change in fair value of earn-out milestone liability
Stock-based compensation
Change of deferred income tax asset
Loss on extinguishment of debt
Write-off of note receivable (Transomic)
Impairment of in-process research and development
Amortization of deferred finance charges and debt discount associated with note payable
Net changes in:
Accrued interest receivable on investment securities
Advances, deposits, and other current assets
Other assets
Accounts payable and accrued liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchases of investment securities
Proceeds from sale and maturity of investment securities
Purchases of property and equipment
Net cash provided by investing activities
Cash flows from financing activities:
Proceeds from redeemable convertible preferred stock offering
Payment upon redemption of redeemable convertible preferred stock
Proceeds from sale of common stock equity, net of issuance costs
Payoff of the SVB loan and accrued end-of-term fees
Net cash (used in) provided by financing activities
Net change in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year
Supplemental disclosure of cash flow information:
Income taxes paid
Interest
Non-Cash Investing and Financing Activities
Recognition of right of use asset and liability
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Sale of equity through equity financing facilities
Sale of equity through equity financing facilities, shares
Issuance of common stock upon exercise of restricted options
Issuance of common stock upon exercise of restricted options, shares
Realized and unrealized gains, net, on investment securities
Stock-based compensation expense
Effect of reverse stock split
Effect of reverse stock split, shares
Issuance of preferred stock upon financing
Issuance of preferred stock upon financing, shares
Redemption of preferred stock
Redemption of preferred stock, shares
Issuance of common stock for restricted options
Issuance of common stock for restricted options, shares
Balance
Balance, shares
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance [Table Text Block]
Company Selected Measure Name
Named Executive Officers, Footnote [Text Block]
Peer Group Issuers, Footnote [Text Block]
Changed Peer Group, Footnote [Text Block]
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote [Text Block]
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote [Text Block]
Equity Valuation Assumption Difference, Footnote [Text Block]
Compensation Actually Paid vs. Total Shareholder Return [Text Block]
Compensation Actually Paid vs. Net Income [Text Block]
Compensation Actually Paid vs. Company Selected Measure [Text Block]
Total Shareholder Return Vs Peer Group [Text Block]
Compensation Actually Paid vs. Other Measure [Text Block]
Tabular List [Table Text Block]
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss) Attributable to Parent
Company Selected Measure Amount
Other Performance Measure Amount
Adjustment to Compensation Amount
PEO Name
Measure Name
Non-GAAP Measure Description [Text Block]
Additional 402(v) Disclosure [Text Block]
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis [Text Block]
Stock Price or TSR Estimation Method [Text Block]
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined [Text Block]
Forgone Recovery, Individual Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability [Text Block]
Outstanding Recovery, Individual Name
Outstanding Recovery Compensation Amount
Restatement Does Not Require Recovery [Text Block]
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure [Text Block]
Award Timing Method [Text Block]
Award Timing Predetermined [Flag]
Award Timing MNPI Considered [Flag]
Award Timing, How MNPI Considered [Text Block]
MNPI Disclosure Timed for Compensation Value [Flag]
Awards Close in Time to MNPI Disclosures [Table Text Block]
Awards Close in Time to MNPI Disclosures, Individual Name
Award Underlying Securities Amount
Award Exercise Price
Award Grant Date Fair Value
Underlying Security Market Price Change, Percent
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted [Flag]
Insider Trading Policies and Procedures Not Adopted [Text Block]
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Organization, Consolidation and Presentation of Financial Statements [Abstract]
FINANCIAL CONDITION AND GOING CONCERN UNCERTAINTY
Investments, Debt and Equity Securities [Abstract]
INVESTMENTS IN DEBT SECURITIES AVAILABLE FOR SALE
Receivables [Abstract]
RESTRICTED CASH
Fair Values Of Financial Instruments
FAIR VALUES OF FINANCIAL INSTRUMENTS
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT
Payables and Accruals [Abstract]
OTHER ACCRUED LIABILITIES
Debt Disclosure [Abstract]
NOTES PAYABLE
Income Tax Disclosure [Abstract]
INCOME TAXES
Equity [Abstract]
STOCKHOLDERS’ EQUITY
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION
Earn-out Milestone Liability
EARN-OUT MILESTONE LIABILITY
Warrants
WARRANTS
Retirement Benefits [Abstract]
IMUNON EMPLOYEE BENEFIT PLANS
Leases
LEASES
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Technology Development And Licensing Agreements
TECHNOLOGY DEVELOPMENT AND LICENSING AGREEMENTS
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTION
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Description of Business
Basis of Presentation
Use of Estimates
Revenue Recognition
Cash and Cash Equivalents
Fair Value of Financial Instruments
Short-Term Investments
Property and Equipment
Deposits
In-Process Research and Development, Other Intangible Assets and Goodwill
Impairment or Disposal of Long-Lived Assets
Comprehensive Income (Loss)
Research and Development
Net Loss per Share of Common Stock
Income Taxes
Stock-Based Compensation
Recent Accounting Pronouncements
SCHEDULE OF COST, FAIR VALUE AND MATURITIES OF SHORT TERM INVESTMENTS
SUMMARY OF INVESTMENT SECURITIES GROSS UNREALIZED GAINS (LOSSES)
SUMMARY OF NET REALIZED LOSSES ON SALES OF AVAILABLE FOR SALE SECURITIES AND INVESTMENT INCOME INTEREST AND DIVIDENDS
SCHEDULE OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS
SCHEDULE OF FAIR VALUE OF ASSETS ACQUIRED
SUMMARY OF PROPERTY AND EQUIPMENT
SCHEDULE OF OTHER ACCRUED LIABILITIES
SCHEDULE OF DEBT
SCHEDULE OF INCOME TAX PROVISION (BENEFIT)
SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES
SUMMARY OF STOCK OPTIONS
SUMMARY OF NON-VESTED RESTRICTED STOCK AWARDS
SUMMARY OF STOCK OPTIONS OUTSTANDING
SCHEDULE OF ASSUMPTIONS USED TO DETERMINE FAIR VALUE OF OPTIONS GRANTED
SCHEDULE OF CHANGES IN EARN-OUT MILESTONE LIABILITY
SUMMARY OF WARRANT ACTIVITY
SCHEDULE OF LEASE PAYMENTS AND MATURITY OF OPERATING LEASE LIABILITIES
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Accounts receivable
Property plant and equipment useful life
Depreciation expense
Impairment of property or equipment
Number of shares of common stock issuable upon exercise of warrants and equity awards
Net proceeds from sale of net operating losses
Tax benefits of EDA
Direct financing lease, selling loss
Net loss
Fund operation
Cumulated net losses
Cash and cash equivalents, short-term investments
Proceeds from sale of net operating losses
Marketable Securities [Table]
Marketable Securities [Line Items]
Short-term investments - Cost
Short-term investments - Fair Value
Short-term investment maturities - Within 3 months, cost
Short-term investment maturities - Within 3 months, fair value
Short-term investment maturities - Between 3-12 months, cost
Short-term investment maturities - Between 3-12 months, fair value
Total, cost
Total, fair value
Investments with unrealized gains, Fair Value
Investments with unrealized gains, Unrealized Holding Gains (Losses)
Investments with unrealized losses, Fair Value
Investments with unrealized Losses, Unrealized Holding Gains (Losses)
Total, Fair Value
Total, Unrealized Holding Gains (Losses)
Interest and dividends accrued and paid
Realized gains (losses)
Investment income, net
Money market investments, restricted
Total
Line of Credit Facility [Table]
Line of Credit Facility [Line Items]
Restricted investments
Fair Value, Recurring and Nonrecurring [Table]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Earn-out milestone liability
Impairment Effects on Earnings Per Share [Table]
Impairment Effects on Earnings Per Share [Line Items]
Balance
Impairment charge
Balance
Schedule of Finite-Lived Intangible Assets [Table]
Finite-Lived Intangible Assets [Line Items]
Estimated acquisition price
Asset impairment charges
Non-cash charge
Property and equipment gross
Less accumulated depreciation and amortization
Total
Estimated useful life
Amounts due to contract research organizations and other contractual agreements
Accrued payroll and related benefits
Accrued interest
Accrued professional fees
Other
Total
Principal balance at April 21, 2023
Early termination fees
End of term charges
Total payoff amount
Line of credit facility, maximum borrowing capacity
Proceeds from lines of credit
Loan amount withdrawn
Repayments of lines of credit
Restricted cash
Final payment percentage
Long term line of credit
Debt instrument, description
Financing fees and expenses
End of term charge percentage
Interest expense debt
Interest expense
Amortization of debt issuance costs
Gain (loss) on contract termination
Current
Deferred
State and Local
Current
Deferred
Total
Federal statutory rate
State taxes, net of federal tax benefit
Permanent differences
True-Up
Other
Change in valuation allowance and deferred rate change, net
Effective tax rate
Net operating loss carryforwards
Section 174
Other deferred tax assets, net
Subtotal
Valuation allowance
Total deferred tax asset
Operating Loss Carryforwards [Table]
Operating Loss Carryforwards [Line Items]
[custom:ProceedsFromSaleOfNetOperatingLosses]
Operating Loss Carryforwards
Net operating losses, unused
Deferred Tax Assets, Operating Loss Carryforwards
[custom:NetOperatingLossesExpirationDescription]
Income tax examination, description
Net proceeds from sale of net operating losses
Operating Income (Loss)
Schedule of Stock by Class [Table]
Class of Stock [Line Items]
Stock issued during period, value, new issues
Public float
Reverse stock split, description
Stockholders equity note changes in capital structure description
Reverse stock split
Warrants issued
Number of shares sold
Proceeds from sale of stock
Preferred stock, stated value
Share price
Original issue discount rate
Proceeds from issuance of preferred stock
Preferred stock, conversion price
Conversion of stock, shares issued
Proceeds from issuance under placement
Stock issued, shares
Proceeds from issuance of common stock
Placement agent fee description
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number Outstanding, Outstanding, Beginning balance
Weighted Average Exercise Price, Outstanding, Beginning balance
Number Outstanding, Options granted
Weighted Average Exercise Price, Options granted
Number Outstanding, Options canceled or expired
Weighted Average Exercise Price, Options canceled or expired
Number Outstanding, Outstanding, Ending balance
Weighted Average Exercise Price, Outstanding, Ending balance
Weighted Average Remaining Contractual Term (years), Outstanding, Ending balance
Aggregate Intrinsic Value, Outstanding, Ending balance
Number Outstanding, Exercisable, Ending balance
Weighted Average Exercise Price, Exercisable, Ending balance
Weighted Average Remaining Contractual Term (years), Exercisable, Ending balance
Aggregate Intrinsic Value, Exercisable, Ending balance
Number Outstanding, Non-vested stock awards, Outstanding, Beginning balance
Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Beginning balance
Number Outstanding, Non-vested stock awards, Granted
Weighted Average Grant Date Fair Value, Non-vested stock awards, Granted
Number Outstanding, Non-vested stock awards, Vested and issued
Weighted Average Grant Date Fair Value, Non-vested stock awards, Vested and issued
Number Outstanding, Non-vested stock awards, Forfeited
Weighted Average Grant Date Fair Value, Non-vested stock awards, Forfeited
Number Outstanding, Non-vested stock awards, Outstanding, Ending balance
Weighted Average Grant Date Fair Value, Non-vested stock awards, Outstanding, Ending balance
Share-Based Payment Arrangement, Option, Exercise Price Range [Table]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of Exercise Prices, Upper
Options Outstanding, Number
Options Outstanding, Weighted Average Remaining Contractual Term (in years)
Options Outstanding, Weighted Average Exercise Price
Options Exercisable, Number
Options Exercisable, Weighted Average Remaining Contractual Term (in years)
Options Exercisable, Weighted Average Exercise Price
Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit
Risk-free interest rate, minimum
Risk-free interest rate, maximum
Expected volatility, minimum
Expected volatility, maximum
Expected life (in years)
Expected dividend yield
Share-based payment award, shares authorized
Shares available for issuance
Stock options, strike price description
Restricted stock
Exercise price per share
Common stock, reserved for future issuance
Share based compensation
Unrecognized compensation cost
Cost recognized over a weighted-average period
Schedule Of Changes In Earn-out Milestone Liability
Earn-out liabilities, beginning balance
Non-cash gain loss from the adjustment for the change in fair value
Earn-out liabilities, ending balance
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Earnout milestone liability
Earnout payment options description
Non-cash charge on earnout milestone liability
Summary Of Warrant Activity
Number of Warrants Issued, Warrants outstanding, Beginning balance
Weighted Average Exercise Price, Warrants outstanding, Beginning balance
Number of Warrants Issued, warrants expired
Weighted Average Exercise Price, Warrants expired
Number of Warrants Issued, Warrants outstanding, Ending balance
Weighted Average Exercise Price, Warrants outstanding, Ending balance
Aggregate intrinsic value of outstanding warrants
Weighted average remaining contractual terms (years)
Maximum annual contributions per employee, percent
Matching contributions of employee
Schedule Of Lease Payments And Maturity Of Operating Lease Liabilities
2024
2025
2026
2027
2028 and Thereafter
Subtotal future lease payments
Less imputed interest
Total lease liabilities
Operating lease, weighted average remaining lease term
Operating lease, weighted average discount rate, percent
Operating lease, term
Area of land
Payments for rent
Operating lease, cost
Operating lease, payments
Amortization expense
Schedule of Accounts, Notes, Loans and Financing Receivable [Table]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Proceeds from license fees received
Deferred revenue
Deferred revenue amortization period
Convertable and warrants
Gain loss from change in earnout milestone liability.
Amortization of deferred finance charges and debt discount associated with notes payable.
Payoff of the SVB loan and accrued end-of-term fees.
Recognition of right of use asset and liability.
Stock issued during period value reverse stock splits.
Issuance of preferred stock upon financing.
Series A and B Preferred Stock [Member]
Issuance of preferred stock upon financing, shares.
Disclosure of accounting policy for description of business.
Disclosure of accounting policy for deposits.
Issuance of common stock upon exercise of restricted options.
Represents the total number of Shares of common stock issuable upon exercise of warrants and equity awards.
Tax benefits of EDA
Proceeds From Sale Of Net Operating Losses.
Amount of public float.
Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) with single maturity date and allocated without single maturity date, maturing in next rolling three months.
Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three to twelve months.
The current amount of amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).
Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three months.
Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling three to twelve months.
Available for sale securities unrealized gains fair value.
Market Offering Agreement [Member]
Available for sale securities unrealized gains less than twelve months.
Available for sale securities unrealized losses fair value.
Available for sale securities unrealized losses less than twelve months.
Available for sale securities unrealized gains (losses) less than twelve months.
Series A Convertible Redeemable Preferred Stock [Member]
Series B Convertible Redeemable Preferred Stock [Member]
Original issue discount rate.
Silicon Valley Bank [Member]
Securities Purchase Agreement [Member]
April 2022 Registered Direct Offering [Member]
Placement agent fee description.
2018 Stock Incentive Plan [Member]
Stock options, strike price description.
Inducement Option Grants [Member]
Five New Employees [Member]
Equity Stock Awards [Member]
Granted Under 2018 Plan and 2007 Plan [Member]
Inducement Awards [Member]
Stock Options and Restricted Stock Awards [Member]
Inprocess R&D [Member]
EGEN Inc [Member]
IPR&D Drug Technology Platforms [Member]
Non-cash charge.
IPR And D [Member]
Exercise Price One [Member]
Exercise Price Two [Member]
Exercise Price Three [Member]
Earnout Milestone Liability Disclosure [Text Block]
Earnout milestone liability.
Amended Asset Purchase Agreement [Member]
Within One Year of Achieving Milestone [Member]
Earn-out payment options, description.
EGWC, Inc [Member]
10 Business Days of Achieving Milestone [Member]
Non-cash charge on earnout milestone liability.
Schedule Of Changes In Earn Out Milestone Liabilities Table [TextBlock]
Earn-out liabilities, beginning balance.
The amount of gain (loss) from the change in the fair value of earn-out milestone liability.
Disclosure of warrants.
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan.
Sharebased compensation arrangement by sharebased payment award non options outstanding intrinsic value.
Weighted average remaining contractual term for non-option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Lease Agreement [Member]
Disclosure of licensing transaction.
Hisun [Member]
The amortization period for deferred revenue.
Convertible Note Purchase Agreement [Member]
Transomic Technologies, Inc. [Member]
Final Payment Percentage.
End of term charge percentage.
Early termination fee.
End of term charge.
Effective income tax rate reconciliation permanent differences.
Effective income tax rate reconciliation time up.
2021 Registration Statement [Member]
New Jersey [Member]
Federal Income Tax [Member]
No Expiration [Member]
Net operating losses, unused.
Net proceeds from sale of net operating losses
Deferred tax assets legal act.
Net operating losses expiration, description.
Baby Shelf Limitation [Member]
Lessee operating lease liability payments due year five and after year five.
Horizon Technology Finance Corporation [Member]
Assets, Current
Other Long-Term Investments
Other Assets, Noncurrent
Assets
Liabilities, Current
Liabilities
Stockholders' Equity before Treasury Stock
Treasury Stock, Value
Equity, Attributable to Parent
Liabilities and Equity
Operating Expenses
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Contract with Customer, Liability, Revenue Recognized
Unrealized Gain (Loss) on Investments
Increase (Decrease) in Accrued Investment Income Receivable
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Other Operating Assets
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Debt Securities, Available-for-Sale
Payments to Acquire Property, Plant, and Equipment
Net Cash Provided by (Used in) Investing Activities
Payments for Repurchase of Redeemable Convertible Preferred Stock
PaymentoffOfLoanAndAccruedEndoftermFees
Net Cash Provided by (Used in) Financing Activities
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Shares, Outstanding
Stock Redeemed or Called During Period, Shares
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
Finite-Lived Intangible Assets, Net
Impairment Charge on Reclassified Assets
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Current State and Local Tax Expense (Benefit)
Deferred State and Local Income Tax Expense (Benefit)
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Deferred Tax Assets, Gross
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance
Net proceeds from sale of net operating losses [Default Label]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Earn-out liabilities, beginning balance
GainLossFromChangeInFairValueOfEarnOutMilestoneLiability
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount